Featured Content Recommended Free CME/ CE Educational Activities for Healthcare Providers Activity Type Enduring Live in-person Live Webinar Credit Type AACE AANP ACPE ANCC CME COPE CPE MOC NCPD Profession Nurses Nurse Practitioner Optometrist Others Pharmacist Physician Physician Assistant Specialty Allergy and Immunology Anesthesiology Cardiology Dermatology Family Medicine Gastroenterology Geriatrics Hematology/Oncology Infectious Disease Nephrology Neurology Oncology Ophthalmology Otolaryngology (ENT) Palliative Medicine Pathology Pediatrics Psychiatry Pulmonology Radiology Rheumatology Sleep Medicine Urology Evolving Strategies in the Diagnosis and Treatment of Muscle-Invasive Bladder Cancer – Live Read more Advances in the Treatment of Myelofibrosis: Clinical Trial Data of Next Generation Therapeutics – Enduring Webcast Read more Changing Landscape of DLBCL Treatment: ADCs, Bispecific Antibodies, CAR T Therapies, and Combinations – Enduring Webcast Read more Advances in the Treatment of Myelofibrosis: Clinical Trial Data of Next Generation Therapeutics – Live Read more PI3K/ AKT/mTOR Pathway Inhibitors in the Treatment of HR+/HER2- Metastatic Breast Cancer – Enduring Webcast Read more Changing Landscape of DLBCL Treatment: ADCs, Bispecific Antibodies, CAR T Therapies, and Combinations – Live Read more PI3K/AKT/mTOR Pathway Inhibitors in the Treatment of HR+/HER2- Metastatic Breast Cancer – Live Read more Changing Landscape of Diagnosis and Personalized Therapies for Acute Myeloid Leukemia – Enduring Webcast Read more Changing Landscape of Diagnosis and Personalized Therapies for Acute Myeloid Leukemia – Live Read more Advances in the Treatment of Diffuse Large B Cell Lymphoma: ADCs, Bispecific Antibodies, CAR T Therapies and Combinations – Enduring Webcast Read more Myelofibrosis: Symptom Burden, Risk Stratification, and Novel Treatments – Enduring Webcast Read more Advances in the Treatment of Diffuse Large B Cell Lymphoma: ADCs, Bispecific Antibodies, CAR T Therapies and Combinations – Live Read more Myelofibrosis: Symptom Burden, Risk Stratification and Novel Treatments – Live Read more Ovarian Cancer: Optimizing the Management Based on Mutations and Biomarkers to Direct Treatment with PARP Inhibitors and Immunotherapy – Enduring Webcast Read more Ovarian Cancer: Optimizing the Management Based on Mutations and Biomarkers to Direct Treatment with PARP Inhibitors and Immunotherapy – Live Read more Evolving Paradigm of PARP-Inhibitors and Combination Therapies for mCRPC – Enduring Webcast Read more Changing Landscape of Diagnosis and Treatment Options for Multiple Myeloma – Enduring Webcast Read more Changing Landscape of Diagnosis and Treatment of Multiple Myeloma – Live Read more Emerging Strategies in the Immune Checkpoint Inhibitors (ICIs) and the Synergistic Effect of Antibody-Drug Conjugate in Combination with ICIs for Urothelial Carcinoma – Enduring Webcast Read more Hepatocellular Carcinoma: Immune Checkpoint Inhibitors, Multi-Targeted Tyrosine Kinase Inhibitors and the Combination Thereof – Enduring Webcast Read more Advances in Symptom Burden, Risk Stratification, and Treatment of Myelofibrosis – Enduring Webcast Read more Advances in Symptom Burden, Risk Stratification, and Treatment of Myelofibrosis – Live Read more New Strategies in the Diagnosis and Treatment of Follicular Lymphoma: 2022 ASH Update – Enduring Webcast Read more Emerging Strategies in the Treatment of Genitourinary Cancers (Prostate Cancer, Renal Cell Carcinoma and Urothelial Carcinoma) – Enduring Webcast Read more Ovarian Cancer: Mutations, Biomarkers, and Treatment with PARP Inhibitors and Immunotherapy – Enduring Webcast Read more Ovarian Cancer: Mutations, Biomarkers, and Treatment with PARP Inhibitors and Immunotherapy – Live Read more Immune Checkpoint and BRAF/MEK Inhibitor- directed Therapies for Advanced Melanoma – Enduring Webcast Read more Improving Renal Cell Carcinoma Patient Outcomes with Multi-targeted TKIs and Immune Checkpoint Inhibitors – Enduring Webcast Read more Immune Checkpoint and BRAF/MEK Inhibitor- directed Therapies for Advanced Melanoma – Live Read more Improving Renal Cell Carcinoma Patient Outcomes with Multi-targeted TKIs and Immune Checkpoint Inhibitors – Live Read more 1 2 3 4 Next »
